Nav: Home

UTSW researchers identify novel mechanism that protects pancreas from digestive enzymes

January 18, 2017

DALLAS, Jan. 18, 2017 - UT Southwestern Medical Center researchers have uncovered the mechanism by which the stress hormone FGF21 keeps digestive enzymes from damaging the pancreas.

The research, published online this month in Cell Metabolism, points to the possibility of new therapies for pancreatitis, a potentially life-threatening inflammation of the pancreas.

Pancreatitis can have many causes, including heavy, long-term alcohol drinking, gallstones, and certain hereditary conditions. About 210,000 U.S. residents are hospitalized with acute pancreatitis annually, according to the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases.

Dr. David Mangelsdorf and Dr. Steven Kliewer - who have run a joint laboratory at UT Southwestern since 2002 - earlier reported that the liver hormone FGF21, or fibroblast growth factor 21, acts via the brain's reward pathway to reduce the desire for sugar and alcohol in mammals. In November, they published a collaborative study with European researchers comparing the genomes of more than 105,000 light and heavy social drinkers. That investigation identified a gene variant for the brain's FGF21 receptors that suppresses the desire to drink alcohol.

They then turned their attention from FGF21's effects in the central nervous system to the digestive system, where another mystery awaited.

"Previous studies had shown that FGF21 protected the pancreas, but it was unknown how or by what mechanism," said Dr. Mangelsdorf, Chair of Pharmacology and a Howard Hughes Medical Institute Investigator. "We found that FGF21 has a novel, unexpected role in stimulating the pancreas to secrete digestive enzymes into the intestine."

The work may someday lead to new therapies for pancreatitis, said Dr. Kliewer, Professor of Molecular Biology and Pharmacology and holder of the Nancy B. and Jake L. Hamon Distinguished Chair in Basic Cancer Research. Drs. Mangelsdorf and Kliewer are corresponding authors of the study.

The study reveals yet another surprising effect of FGF21. When produced in the liver, FGF21 works on the central nervous system like a hormone - a substance created in one part of the body that exerts effects on other parts. In contrast, FGF21 made in the pancreas acts locally, affecting only that organ, the researchers found.

The researchers report that the same FGF21 receptor complex found in the brain is also present in the pancreas, the organ located behind the stomach that makes enzymes used in digestion. Under normal conditions, the pancreas makes enzymes that remain inactive (known as zymogen granules) until they travel through the pancreatic ducts and arrive in the intestine, where they become activated and help digest food. When the pancreatic ducts become blocked, the powerful enzymes can activate while still inside the pancreas and begin to digest the glandular organ itself, they explained.

In one experiment, the researchers observed that mice genetically unable to make FGF21 overproduced zymogen granules (the enzyme precursors) in the pancreas. This effect was reversed when the mice received FGF21 infusions.

"There was no evidence of pancreatitis in those mice, only a significant increase in the amount of pancreatic enzymes, and indications that having FGF21 helps clear those enzymes from the pancreas," Dr. Kliewer said.

In another experiment, they found that mice genetically engineered to overproduce FGF21 were protected from injury when exposed to a pancreatic toxin. Conversely, mice lacking FGF21 were more susceptible to damage from the toxin.

"Pancreatic FGF21 is a digestive enzyme secretion stimulator whose function is to maintain enzyme balance in the pancreas," said Dr. Mangelsdorf, who also holds the Alfred G. Gilman Distinguished Chair in Pharmacology, and the Raymond and Ellen Willie Distinguished Chair in Molecular Neuropharmacology in Honor of Harold B. Crasilneck, Ph.D.

"One of the big inducers of pancreatitis is alcohol consumption. So, this hormone might someday be used to treat one of the key adverse effects of alcoholism," Dr. Mangelsdorf said.

FGF21 was first described in association with dietary stresses such as starvation and high-fat diets. It is also produced when mammals consume carbohydrates and alcohol. Because of FGF21's unique effects, drug forms of the protein are being evaluated for the treatment of obesity and type 2 diabetes.

The researchers stressed that any potential therapeutics will need to address some unusual side effects seen in their previous mouse studies, such as bone loss, increased levels of the so-called fight-or-flight hormones called glucocorticoids, and suppressed fertility in female mice. Because FGF21's hormonal effects on the central nervous system work via the brain's reward pathway, there is also concern about possible adverse effects on mood, they said.

"FGF21 has remarkable pharmacologic effects," Dr. Mangelsdorf said. "This study suggests an intriguing role in the body's reaction to stresses in the digestive system, but there is more work to be done."

UT Southwestern co-authors, all in Pharmacology, include: co-lead authors Dr. Katie Coate, a former postdoctoral researcher, and graduate student Dr. Genaro Hernandez; Assistant Instructor Dr. Curtis Thorne; postdoctoral researcher Dr. Shengyi Sun; undergraduate researcher Thao D.V. Le; and research technician Kevin Vale.

The research was supported by the National Institutes of Health, the Robert A. Welch Foundation, a National Science Foundation Graduate Research Fellowship, and the Howard Hughes Medical Institute. Novo Nordisk provided the recombinant FGF21 used in the experiments.

Dr. Mangelsdorf is a founder and member of the scientific advisory board of Metacrine, a biotech company that seeks to develop anti-obesity drugs.

Earlier UTSW findings on FGF21
-end-
  • A 2016 international study identified a gene variant for the brain's FGF21 receptors that suppresses the desire to drink alcohol.
  • A 2015 study found that FGF21 made in the liver works via the brain's reward pathway to reduce cravings for sweets and alcohol in mammals.
  • A 2014 study showed that FGF21 causes weight loss in obese mice by acting on the brain.
  • A 2012 study revealed that FGF21 markedly extends life span in mice.
About UT Southwestern Medical CenterUT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including six who have been awarded Nobel Prizes since 1985. The faculty of almost 2,800 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in about 80 specialties to more than 100,000 hospitalized patients and oversee approximately 2.2 million outpatient visits a year.

 
-end-
This news release is available on our website at http://www.utsouthwestern.edu/news

To automatically receive news releases from UT Southwestern via email, subscribe at http://www.utsouthwestern.edu/receivenews

UT Southwestern Medical Center

Related Alcohol Articles:

Sobering new data on drinking and driving: 15% of US alcohol-related motor vehicle fatalities involve alcohol under the legal limit
A new study in the American Journal of Preventive Medicine, published by Elsevier, found that motor vehicle crashes involving drivers with blood alcohol concentrations (BACs) below the legal limit of 0.08 percent accounted for 15% of alcohol-involved crash deaths in the United States.
Alcohol marketing and underage drinking
A new study by a research team including scientists from the Prevention Research Center of the Pacific Institute for Research and Evaluation provides a systematic review of research that examines relationships between exposure to alcohol marketing and alcohol use behaviors among adolescents and young adults.
Alcohol-induced deaths in US
National vital statistics data from 2000 to 2016 were used to examine how rates of alcohol-induced deaths (defined as those deaths due to alcohol consumption that could be avoided if alcohol weren't involved) have changed in the US and to compare the results by demographic groups including sex, race/ethnicity, age, socioeconomic status and geographic location.
Cuts in alcohol duty linked to 2000 more alcohol-related deaths in England
Government cuts to alcohol taxes have had dramatic consequences for public health, including nearly 2000 more alcohol-related deaths in England since 2012, according to new research from the University of Sheffield's School of Health and Related Research (ScHARR).
Integrated stepped alcohol treatment for people in HIV care improves both HIV & alcohol outcomes
Increasing the intensity of treatment for alcohol use disorder (AUD) over time improves alcohol-related outcomes among people with HIV, according to new clinical research supported by the National Institutes of Health.
The Lancet:Targets to reduce harmful alcohol use are likely to be missed as global alcohol intake increases
Increasing rates of alcohol use suggest that the world is not on track to achieve targets against harmful alcohol use, according to a study of 189 countries' alcohol intake between 1990-2017 and estimated intake up to 2030, published in The Lancet.
Alcohol-induced brain damage continues after alcohol is stopped
Now, a joint work of the Institute of Neuroscience CSIC-UMH, in Alicante, and the Central Institute of Mental Health of Mannheim, in Germany, has detected, by means of magnetic resonance, how the damage in the brain continues during the first weeks of abstinence, although the consumption of alcohol ceases.
Does alcohol consumption have an effect on arthritis?
Several previous studies have demonstrated that moderate alcohol consumption is linked with less severe disease and better quality of life in patients with rheumatoid arthritis, but a new Arthritis Care & Research study suggests that this might not be because drinking alcohol is beneficial.
How genes affect tobacco and alcohol use
A new study gives insight into the complexity of genetic and environmental factors that compel some of us to drink and smoke more than others.
Cutting societal alcohol use may prevent alcohol disorders developing -- Otago research reveals
Society must take collective responsibility to reduce the harm caused by alcohol use disorders, a University of Otago academic says.
More Alcohol News and Alcohol Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.